Form 4: Perrigo Executive Roberto Khoury Reports Significant Stock Transactions and RSU Grants

Perrigo Co plc's EVP and President of CSCI, Roberto Khoury, reported multiple transactions involving the acquisition and disposition of ordinary shares, alongside new grants and vesting of Restricted Stock Units.

Summary

• Roberto Khoury, EVP and President of CSCI at Perrigo Co plc (PRGO), engaged in several stock transactions on June 6, 2025.
• He acquired a total of 10,868 ordinary shares through the exercise of derivative securities (7,888 shares and 2,980 shares), both at a price of $26.16 per share.
• Concurrently, he disposed of a total of 5,663 ordinary shares (4,110 shares and 1,553 shares) at $26.16 per share, likely to cover tax obligations related to the vesting/exercise.
• Khoury was granted an additional 21,101 Restricted Stock Units (RSUs) which will vest in three equal annual installments starting June 6, 2026.
• He also saw 7,888 RSUs vest (vesting in two equal annual installments beginning June 7, 2025) and 2,980 RSUs vest (vesting in three equal annual installments beginning June 7, 2025), which were then converted to ordinary shares.
• Following these transactions, Khoury directly beneficially owns 5,205 ordinary shares and 27,060 Restricted Stock Units (comprising 21,101 newly granted RSUs and 5,959 remaining from a prior grant).

Sentiment

Score: 6

Explanation: Neutral to slightly positive. The filing primarily reports routine insider transactions, including new RSU grants which are generally positive for executive retention and alignment, balanced by dispositions for tax purposes, which are common and expected.

Positives

• Grant of 21,101 new Restricted Stock Units to a key executive, indicating continued incentive alignment with company performance and long-term retention.
• Exercise of existing Restricted Stock Units, demonstrating value realization for the executive and conversion of equity awards into direct share ownership.

Negatives

• Disposition of 5,663 ordinary shares, although likely for tax purposes related to RSU vesting, reduces the executive's direct share ownership.

Future Outlook

The grant of new Restricted Stock Units with vesting extending to June 2026 indicates a long-term incentive structure for the executive, aligning their interests with future company performance and shareholder value creation.

Industry Context

This Form 4 filing reflects routine insider compensation and share management activities within a publicly traded company in the consumer healthcare sector. Such transactions are common for executives receiving equity-based compensation as part of their overall remuneration package.

Comparison to Industry Standards

• Form 4 filings are standard regulatory disclosures for insider transactions across all industries, ensuring transparency in executive stock ownership changes.
• The specific details of RSU grants and vesting schedules are typical for executive compensation packages in large public companies, aiming to align executive incentives with shareholder value over multi-year periods.
• Without specific compensation benchmarks for similar roles in the consumer healthcare industry, a direct comparison of the compensation value or structure to industry peers is not possible from this document alone.

Stakeholder Impact

• Shareholders: The transactions reflect standard executive compensation practices and share management, which can align executive interests with shareholder value. The dispositions for tax purposes are routine and not indicative of a lack of confidence.
• Employees: No direct impact on general employees is indicated by this specific filing.

Next Steps

• Vesting of 21,101 newly granted Restricted Stock Units will commence on June 6, 2026, in three equal annual installments.
• Vesting of 7,888 Restricted Stock Units will continue in two equal annual installments beginning June 7, 2025.
• Vesting of 2,980 Restricted Stock Units will continue in three equal annual installments beginning June 7, 2025.

Key Dates

Recommendation

Keywords

Perrigo Co plc, PRGO, Form 4, Insider Trading, Stock Transactions, Restricted Stock Units, Executive Compensation, Roberto Khoury, Beneficial Ownership